India Regulators Take On Assuring Patient Compensations Paid
This article was originally published in PharmAsia News
Executive Summary
India regulators responded quickly with an investigation and an advisory to state authorities to monitor Johnson & Johnson's $2.5 billion settlement plus subsequent medical expenses for its DePuy Orthopedics unit's hip implant.